Chemotherapy for Hepatocellular Carcinoma: Current Evidence and Future Perspectives

about

IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.

P2860

Q54966891-A38E87E5-F94F-4780-A5AC-680410A5A778

P2860

Chemotherapy for Hepatocellular Carcinoma: Current Evidence and Future Perspectives

Item

http://www.wikidata.org/entity/Q41706847

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Chemotherapy for Hepatocellular Carcinoma: Current Evidence and Future Perspectives

@en

type

Item

label

Chemotherapy for Hepatocellular Carcinoma: Current Evidence and Future Perspectives

@en

prefLabel

Chemotherapy for Hepatocellular Carcinoma: Current Evidence and Future Perspectives

@en

P1476

Chemotherapy for Hepatocellular Carcinoma: Current Evidence and Future Perspectives

@en

P2093

Antonio Gasbarrini

http://www.w3.org/2001/XMLSchema#string

Emanuele Rinninella

http://www.w3.org/2001/XMLSchema#string

Irene Spinelli

http://www.w3.org/2001/XMLSchema#string

Lucia Cerrito

http://www.w3.org/2001/XMLSchema#string

Maria Cristina Mele

http://www.w3.org/2001/XMLSchema#string

Maurizio Pompili

http://www.w3.org/2001/XMLSchema#string

P2860

Epigenetic Activation of Wnt/β-Catenin Signaling in NAFLD-Associated Hepatocarcinogenesis

EGFR Signaling in Liver Diseases

Lenvatinib: Role in thyroid cancer and other solid tumors

Mechanisms of hepatocellular carcinoma and challenges and opportunities for molecular targeted therapy

Immune checkpoint blockade in hepatocellular carcinoma: current progress and future directions

Management of hepatocellular carcinoma: An update

Global cancer statistics, 2002

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Sorafenib in advanced hepatocellular carcinoma

P304

235-248

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.14218/JCTH.2017.00002

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marco Cintoni

P577

2017-06-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28936405

http://www.w3.org/2001/XMLSchema#string

P932

5606970

http://www.w3.org/2001/XMLSchema#string

Chemotherapy for Hepatocellular Carcinoma: Current Evidence and Future Perspectives

about

P2860

P2860

Chemotherapy for Hepatocellular Carcinoma: Current Evidence and Future Perspectives

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932